CATALOGO DEI PRODOTTI DELLA RICERCA

CALABRESE, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.960
EU - Europa 6.894
AS - Asia 5.296
SA - Sud America 835
AF - Africa 232
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.243
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.773
RU - Federazione Russa 3.162
SG - Singapore 2.118
CN - Cina 1.348
IT - Italia 917
GB - Regno Unito 733
BR - Brasile 667
VN - Vietnam 541
HK - Hong Kong 452
DE - Germania 407
SE - Svezia 330
FR - Francia 324
FI - Finlandia 295
IE - Irlanda 263
KR - Corea 173
TR - Turchia 141
CA - Canada 107
IN - India 92
ID - Indonesia 84
UA - Ucraina 75
NL - Olanda 72
AR - Argentina 66
JP - Giappone 63
BD - Bangladesh 60
PL - Polonia 58
AT - Austria 57
MX - Messico 52
ES - Italia 48
ZA - Sudafrica 47
TG - Togo 35
BJ - Benin 32
IQ - Iraq 32
NG - Nigeria 32
EC - Ecuador 24
BE - Belgio 23
UZ - Uzbekistan 22
CO - Colombia 21
MA - Marocco 20
PH - Filippine 20
AU - Australia 16
AE - Emirati Arabi Uniti 15
CL - Cile 15
EG - Egitto 15
LT - Lituania 15
SA - Arabia Saudita 15
PK - Pakistan 14
AZ - Azerbaigian 12
PY - Paraguay 12
CH - Svizzera 11
HR - Croazia 11
MK - Macedonia 11
JO - Giordania 10
MY - Malesia 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
IL - Israele 9
KE - Kenya 9
VE - Venezuela 9
AL - Albania 8
RO - Romania 8
RS - Serbia 8
KZ - Kazakistan 7
PE - Perù 7
PT - Portogallo 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
GR - Grecia 6
OM - Oman 6
QA - Qatar 6
BO - Bolivia 5
CY - Cipro 5
SN - Senegal 5
UY - Uruguay 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
CG - Congo 4
DK - Danimarca 4
ET - Etiopia 4
GY - Guiana 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
NO - Norvegia 4
TW - Taiwan 4
BH - Bahrain 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
GD - Grenada 2
IR - Iran 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
Totale 20.193
Salva come PNG Salva come JPEG
Città #
Ashburn 1.160
Moscow 1.108
Singapore 1.043
San Jose 776
Chandler 682
Dallas 649
Southend 490
Hong Kong 442
Verona 395
Beijing 268
Dublin 258
The Dalles 241
Munich 186
Los Angeles 170
Ho Chi Minh City 166
Jacksonville 166
New York 161
Helsinki 159
Woodbridge 151
Ann Arbor 133
Hanoi 102
Istanbul 100
Princeton 100
Houston 97
Redmond 97
São Paulo 95
Lawrence 93
Wilmington 79
Jinan 71
Redondo Beach 68
Buffalo 66
Jakarta 63
London 60
Milan 55
Montreal 55
Council Bluffs 54
Dong Ket 52
Warsaw 52
Orem 51
Tokyo 51
Lappeenranta 48
Nanjing 48
Santa Clara 47
Lancaster 45
Tianjin 45
Shenyang 44
Sindelfingen 44
Columbus 41
Turku 41
Atlanta 39
Hebei 39
Seattle 39
Johannesburg 36
Lomé 35
Chennai 34
Nuremberg 34
Washington 33
Amsterdam 32
Cotonou 32
Redwood City 32
Brooklyn 30
Chicago 30
Abuja 29
Rome 29
Seoul 29
Guangzhou 28
Phoenix 28
Vienna 28
Changsha 27
Denver 26
Frankfurt am Main 26
Zhengzhou 26
Haikou 25
Ningbo 24
Stockholm 24
Paris 23
Haiphong 22
Rio de Janeiro 22
Taizhou 22
Brussels 21
Da Nang 21
Mexico City 21
Boardman 20
Poplar 20
Toronto 20
Manchester 19
Nanchang 19
Tashkent 18
Des Moines 17
Falkenstein 17
Hangzhou 17
Norwalk 17
Ankara 16
Bologna 16
San Francisco 16
Mumbai 15
Belo Horizonte 14
City of London 14
Dongguan 14
Boston 13
Totale 11.916
Salva come PNG Salva come JPEG
Nome #
Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis 391
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 301
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 251
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 218
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 217
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 216
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 214
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 214
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 210
A case of acute fulminant multiple sclerosis treated with alemtuzumab 208
Can DTI and 3D-SHORE based indices differentiate RRMS from PMS Patients? 206
A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia 202
Coping strategies and their impact on quality of life and physical disability of people with multiple sclerosis 197
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 194
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 194
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 184
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 184
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 183
Explainable 3D-CNN for multiple sclerosis patients stratication 180
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 180
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results 179
Assessing response to interferon-β in a multicenter dataset of patients with MS 177
Epilepsy in multiple sclerosis: The role of temporal lobe damage 177
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 176
Response to Nagai et al. 174
A videogame-based approach to measuring information processing speed in multiple sclerosis patients 173
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes 170
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 168
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 168
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 166
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 165
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 164
The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis 163
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 162
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 162
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 162
Interpretable Deep Learning as a means for decrypting disease signature in Multiple Sclerosis 160
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 159
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients 158
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 158
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 157
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 157
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 157
Visual-attentional load unveils slowed processing speed in multiple sclerosis patients: a pilot study with a tablet-based videogame 155
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 153
Lost in classification: lower cognitive functioning in apparently cognitive normal newly diagnosed RRMS patients 153
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 152
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 152
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 151
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 148
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 148
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 147
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 146
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 146
Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical multiple sclerosis lesion detection 145
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 145
Correlating Dti and 3d-Shore Based Indices with Neurological Disability Scores of Multiple Sclerosis Patients 145
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 144
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 143
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients 143
False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm 142
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 141
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 141
"What is hidden behind the mask?" Facial emotion recognition at the time of COVID-19 pandemic in cognitively normal multiple sclerosis patients 141
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 140
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 138
Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation 138
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 137
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 137
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 136
Exploring the origins of grey matter damage in multiple sclerosis. 136
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 134
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 131
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 131
Impact of model selection procedure on Deep Neural Networks ensemble for the Choroid Plexus segmentation in Multiple Sclerosis 130
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 127
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 126
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 125
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis 124
Explainable deep learning for decrypting disease signatures in multiple sclerosis 124
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 124
ASCHOPLEX: A generalizable approach for the automatic segmentation of choroid plexus 124
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 123
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 122
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 122
Heterogeneity of cortical lesions in multiple sclerosis: An MRI perfusion study 121
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 121
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 120
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 120
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 120
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 119
Multiple sclerosis and epilepsy: much more than a coincidence 119
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 118
Multivariate data analysis suggests the link between brain microstructure and cognitive impairment in multiple sclerosis 117
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 116
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes. 112
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 111
Classification of upper limb spasticity patterns in patients with multiple sclerosis: a pilot observational study 111
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 111
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis 110
Totale 15.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.175
article - articoli 63.876
book - libri 0
conference - conferenze 6.839
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 460
Totale 142.350
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021181 0 0 0 0 0 0 0 0 0 34 68 79
2021/2022870 48 263 5 125 18 19 34 53 27 30 64 184
2022/20231.895 116 244 158 337 129 415 45 114 220 22 53 42
2023/20241.235 38 88 105 132 124 238 102 77 17 94 154 66
2024/20253.674 140 169 144 615 159 203 205 223 620 250 315 631
2025/202610.652 720 580 722 1.847 2.968 657 952 576 975 655 0 0
Totale 20.523